# OnCo record nanjing-leads-biolabs (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/nanjing-leads-biolabs/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "nanjing-leads-biolabs" ;
  schema:name "Nanjing Leads Biolabs"@en ;
  schema:alternateName "Nanjing Leads Biolabs Co.,Ltd"@en ;
  schema:description "Nanjing Leads Biolabs is a China-based biotechnology company running 8 late-stage cancer trials of LBL-024 and LBL-034 in triple-negative breast cancer, non-small-cell lung cancer and hepatocellular carcinoma."@en ;
  schema:url <https://onco.cc/companies/nanjing-leads-biolabs/>, <https://www.leadsbiolabs.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.leadsbiolabs.com>, <https://clinicaltrials.gov/search?lead=Nanjing%20Leads%20Biolabs%20Co.%2CLtd> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/esophageal/>, <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/ovarian/> ;
  onco:trials <https://onco.cc/trials/nct07042802/>, <https://onco.cc/trials/nct05170958/>, <https://onco.cc/trials/nct06049290/>, <https://onco.cc/trials/nct07331155/>, <https://onco.cc/trials/nct06783647/>, <https://onco.cc/trials/nct07111546/>, <https://onco.cc/trials/nct07390383/>, <https://onco.cc/trials/nct07281976/> .